Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 7/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.34 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6804634 | 1.00 | ACACB (0.39) | ACACBTP53ESR1KCNH2MTNR1A | |
| SCHEMBL6805228 | 0.93 | ACACB (0.43) | ACACBTP53ESR1KCNH2RXFP1 | |
| SCHEMBL6805231 | 0.93 | ACACB (0.43) | ACACBTP53ESR1KCNH2RXFP1 | |
| SCHEMBL6804172 | 0.84 | ABCC9 (0.39) | ACACBESR1KCNH2MTNR1BMRGPRX4 | |
| SCHEMBL6804169 | 0.84 | ABCC9 (0.39) | ACACBESR1KCNH2MTNR1BMRGPRX4 | |
| SCHEMBL6676771 | 0.84 | ADRB1 (0.43) | ACACBESR1KCNH2SLC6A4LMNA | |
| SCHEMBL6676768 | 0.84 | ADRB1 (0.43) | ACACBESR1KCNH2SLC6A4LMNA | |
| SCHEMBL6805230 | 0.81 | ACACB (0.43) | ACACBESR1KCNH2LMNA | |
| SCHEMBL6805226 | 0.81 | ACACB (0.43) | ACACBESR1KCNH2LMNA | |
| SCHEMBL6541155 | 0.81 | MTNR1A (0.48) | ACACBESR1KCNH2MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FANCD2, FANCI, HRH2 | ACACB 1800/4885TP53 3318/4885ESR1 3850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.